Ever Source Wealth Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 277 shares of COLL stock, worth $9,027. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277
Previous 277
-0.0%
Holding current value
$9,027
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding COLL
# of Institutions
249Shares Held
36.2MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$189 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.9 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$76.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$69.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.11B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...